Duran-Reynals, F.: The effect of extracts of certain organs from the normal and immunized animals on the infecting power of vaccine virus . J. Exper. Med.50: 327, 1929.
2.
Duran-Reynals, F., Chairman: Conference on the Ground Substance of the Mesenchyme and Hyaluronidase. Ann. N. Y. Acad. Sci.52: 943-1196, 1950.
3.
Ende, M.: Use of Hyaluronidase in Chronic Ulcers: Preliminary Reports, South , M. J., 44: 661 (July) 1951.
4.
Farrar, G.E., JR.: Medical Director, Wyeth, Inc., Philadelphia , Personal communication.
5.
Hechter, O., Dopkeen, S.K., AND Yudell, M.H.: The clinical use of hyaluronidase in hypodermoclysis. J. Pediat.30: 645, 1947.
6.
Kirby, C.K., Eckenhoff, J.E., AND Looby, J.P.: The use of hyaluronidase with local anesthetic agents in nerve block and infiltration anesthesia. Surgery, 25: 101, 1949.
7.
McClean, D.: Studies on diffusing factors; methods of assay of hyaluronidase and their correlation with skin diffusing activity. Biochem. J.37: 169, 1943.
8.
Meyer, K.: The biological significance of hyaluronic acid and hyaluronidase. Physiol. Rev.27: 335, 1947.
9.
Popkin, R.J. : The use of hyaluronidase by iontophoresis in the treatment of generalized scleroderma. J. Invest. Dermat.16: 97, 1951.
10.
Popkin, R.J. : An evaluation of some dihydrogenated alkaloids of ergot in the management of chronic peripheral vascular diseases. Angiology2: 114, 1951.
11.
Sharnoff, J.G. , Carideo, J.L., AND Stein, J.D.: Cortisone treated scleroderma. J. A. M. A.145: 1230 (April 21) 1951.
12.
Turner, J.P. AND Schmidt, F.R.: Treatment of scleroderma with procaine . J. A. M. A.144: 1560 (Dec. 30) 1950.
13.
Wuerthele, V.: Scleroderma treated with promin with report of a case. J. M. Soc., New Jersey44: 52, 1947.
